Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-11-13
1988-03-15
Kight, John
Drug, bio-affecting and body treating compositions
Lymphokine
424 86, 424 87, 514885, 935106, 935107, 436548, A61K 39395
Patent
active
047312440
ABSTRACT:
A method of seriatim administration to a patient of a plurality of ligands, each of which contains an antigen combining site of a monoclonal antibody of distinct idiotype, is disclosed. This method is useful for therapeutic as well as diagnostic purposes.
REFERENCES:
Nepon et al., PNAS. 81, 1984, pp. 2864-2867.
Muller et al. J Exp. Med. 159, 1984, pp. 758-772.
Ovary, Int. Archs Allergy Appl. Immunol. 69, 1982, pp. 385-392.
Takemori et al., Eur. J Immunol. 14, 1984, pp. 656-667.
Brown, J Immunol. 132, 1984, pp. 2715-2723.
Chatenoud et al., J Immunol. 137, 1986, pp. 830-838.
Chatenoud et al., Transplant. Proc., vol. 15, No. 1, pp. 643-645 (Mar. 1983).
Jaffers et al., Transplant Proc., vol. 15, No. 1, pp. 646-648 (Mar. 1983).
Goldstein Gideon
Newman Walter
Rao Patricia E.
Talle Mary A.
Draper Garnette D.
Grochala Richard J.
Kight John
Ortho Pharmaceutical Corporation
LandOfFree
Monoclonal antibody therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1925740